Genes Transfer is the Main Process for Prediction of a Drug or Vaccine Against SARS-C0V-2

Abstract

Gene transfer is emerging as a method for a rapid response to the SARS-CoV-2 epidemic. Both experimental therapeutic solutions and vaccines are subject to preclinical and in some clinical cases. Many of these approaches make use of gene transfer techniques that, especially vaccines, allow a faster initial development pathway than conventional approaches. The unprecedented urgency of this global crisis may cause these antiviral drugs and genetic vaccines, if safe and effective, to be spread on a larger scale than anything else will be available for all people. Depending on the regulatory approval pathway, it may also happen at a pace never seen before in drug development as a result of gene transfer. Hopefully, in the coming days, the clinical trials of will end and the vaccines become available everywhere.